Medicare Enrolled

Dr. Kelly Alberda, M.D.

Family Medicine · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
5222 BURNET RD STE 200, Austin, TX 78756
5124599889
In practice since 2006 (19 years)
NPI: 1972525376 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alberda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alberda? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alberda

Dr. Kelly Alberda is a family medicine in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Alberda performed 1,692 Medicare services across 1,165 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alberda received a total of $8,581 from 39 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alberda is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 17% volume in TX$ $8,581 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,692
Medicare services
Top 17% in TX for family medicine
1,165
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~89 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)684$85$136
Office visit, established patient (20-29 min)276$52$96
Annual wellness visit, follow-up186$132$147
Annual depression screening99$19$19
Drug injection, under skin or into muscle96$10$37
Flu vaccine, high-dose72$68$92
Flu vaccine administration64$31$44
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use31$282$500
Pneumonia vaccine administration31$31$41
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza29$56$165
Detection test by immunoassay technique for streptococcus, group a (strep)26$16$75
Urinalysis, manual20$3$20
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment19$169$187
Electrocardiogram (EKG), 12-lead18$10$15
Office visit, established patient, complex (40-54 min)16$129$203
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit13$169$187
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus12$35$95
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,581
Total received (2018-2024)
Avg $1,226/year across 7 years
Top 6% in TX for family medicine
39
Companies
236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,869 (56.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,711 (43.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$983
2023
$1,011
2022
$723
2021
$711
2020
$286
2019
$2,827
2018
$2,040

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme Corporation
$4,831
Novo Nordisk Inc
$720
AstraZeneca Pharmaceuticals LP
$329
AbbVie Inc.
$326
Abbott Laboratories
$277
Boehringer Ingelheim Pharmaceuticals, Inc.
$259
PFIZER INC.
$229
Lilly USA, LLC
$207
ABBVIE INC.
$191
Bayer Healthcare Pharmaceuticals Inc.
$160
Amarin Pharma Inc.
$84
Takeda Pharmaceuticals U.S.A., Inc.
$80
GlaxoSmithKline, LLC.
$74
Exact Sciences Corporation
$74
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$66
Currax Pharmaceuticals LLC
$66
SANOFI PASTEUR INC.
$43
Amneal Pharmaceuticals LLC
$43
Horizon Therapeutics plc
$43
IDORSIA PHARMACEUTICALS US INC
$39
Biohaven Pharmaceutical Holding Company Ltd.
$38
Biohaven Pharmaceuticals, Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$37
Astellas Pharma US Inc
$32
Amgen Inc.
$29
Exeltis, USA Inc.
$29
Janssen Pharmaceuticals, Inc
$24
Gilead Sciences, Inc.
$22
Axsome Therapeutics, Inc.
$22
Allergan, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$21
IBSA Pharma Inc.
$20
Genentech USA, Inc.
$18
Clarus Therapeutics Inc.
$17
Corcept Therapeutics
$16
ViiV Healthcare Company
$16
Bolton Medical Inc
$15
Kowa Pharmaceuticals America, Inc.
$14
Aytu Bioscience, Inc
$13
Top 3 companies account for 68.5% of total payments
Associated products mentioned in payments ›
AIRSUPRA · APRETUDE · Auvelity · CONTRAVE · CREON · Cologuard Collection Kit · EMGALITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · HUMIRA · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LINZESS · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · NEXPLANON · NURTEC ODT · Natesto · Otezla · Ozempic · PAXLOVID · PENNSAID · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · PRODIGY · QULIPTA · QUVIVIQ · RAYOS · REXULTI · RYBELSUS · Relay Grafts · Rybelsus · SHINGRIX · SLYND · SYMBICORT · SYNTHROID · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · Tirosint · UBRELVY · UNITHROID · VRAYLAR · Vascepa · XIFAXAN · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for family medicine in TX.

Equivalent to $507 per 100 Medicare services performed
Looking for a family medicine in Austin?
Compare family medicines in the Austin area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
802
Per 100K population
61.3
County median income
$97,169
Nearest hospital
AUSTIN STATE HOSPITAL
1.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alberda is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), and high industry engagement (speaking/promotional, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alberda experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Alberda performed 684 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alberda receive payments from pharmaceutical companies?
Yes. Dr. Alberda received a total of $8,581 from 39 companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alberda's costs compare to other family medicines in Austin?
Dr. Alberda's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alberda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →